Acasă › Cancer (toate tipurile) › Texas › Dallas
Studii clinice pentru Cancer (toate tipurile) în Dallas, TX
37 studii pentru Cancer (toate tipurile) caută participanți în și în jurul orașului Dallas (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
În curs de recrutareStudiu observațional
- UT Southwestern Medical Center, Dallas
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- GSK Investigational Site, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
În curs de recrutareFaza 2/3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- și încă 1
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
În curs de recrutareFaza 1
- NEXT Oncology, Dallas
- SCRI at Mary Crowley, Dallas
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
În curs de recrutareFaza 3
- Texas Oncology-Baylor Charles A Sammons Cancer Center, Dallas
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
În curs de recrutareFaza 2/3
- Texas Oncology, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
- UT Southwestern Medical Center, Dallas
Connect for Cancer Prevention Study (Connect)
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Baylor Scott and White Health, Dallas
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
În curs de recrutareFaza 2
- UT Southwestern Medical Center, Dallas
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
În curs de recrutareFaza 1/2
- University of Texas - Southwestern Medical Center /ID# 271914, Dallas
Falcon Real World Evidence Registry
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Baylor Scott & White Health, Dallas
A Phase 1/1b Study of IAM1363 in HER2 Cancers
În curs de recrutareFaza 1
- Mary Crowley Cancer Research, Dallas
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
În curs de recrutareFaza 3
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- Mary Crowley Cancer Research, Dallas
Perioperative FLOT(D) With Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Esophageal Cancer
În curs de recrutareFaza 1
- University of Texas Southwestern Medical Center, Dallas
Project: Every Child for Younger Patients With Cancer
În curs de recrutareStudiu observațional
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Abatacept in Immune Checkpoint Inhibitor Myocarditis
În curs de recrutareFaza 3
- University of Texas Southwestern, Dallas
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
În curs de recrutareFaza 2
- University of Texas Southwestern Medical Center at Dallas, Dallas
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
În curs de recrutareFaza 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of ASP1002 in Adults for Treatment of Solid Tumors
În curs de recrutareFaza 1
- Mary Crowley Cancer Research Center, Dallas
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
În curs de recrutareFaza 1/2
- University of Texas - Southwestern Medical Center /ID# 274360, Dallas
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
În curs de recrutareFaza 1
- Texas Oncology - Dallas - Worth Street /ID# 280064, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
În curs de recrutareStudiu observațional
- Liver Center of Texas, Dallas
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
În curs de recrutareFaza 2
- University of Texas Southwestern Medical Center, Dallas
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
În curs de recrutareFaza 1 timpurie
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
În curs de recrutareFaza 1
- GSK Investigational Site, Dallas
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
În curs de recrutare
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
În curs de recrutareFaza 1
- University of Texas Southwestern Medical Center /ID# 251974, Dallas
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
În curs de recrutareFaza 1/2
- UT Southwestern Medical Center, Dallas
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
În curs de recrutareFaza 1
- GSK Investigational Site, Dallas
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
În curs de recrutareFaza 2
- Texas Oncology, Dallas
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
În curs de recrutareStudiu observațional
- UT Southwestern Medical Centre, Dallas
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- NEXT Dallas, Dallas
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
În curs de recrutareStudiu observațional
- Baylor University Medical Center - Dallas, Dallas
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- NEXT Dallas, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
În curs de recrutareFaza 2
- University of Texas Southwestern Medical Center, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Dallas
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
În curs de recrutareStudiu observațional
- UT Southwestern, Dallas
Studii pentru Cancer (toate tipurile) în alte orașe
- Houston, TX121 studii
- New York City, NY110 studii
- Boston, MA86 studii
- Los Angeles, CA73 studii
- Nashville, TN65 studii
- Philadelphia, PA59 studii
- Durham, NC58 studii
- Washington, DC58 studii
- Chicago, IL51 studii
- Seattle, WA49 studii
- Atlanta, GA49 studii
- Arlington, VA48 studii
Alte studii în Dallas
- Cancer de sân55 studii
- Cancer pulmonar cu celule non-pătrate52 studii
- Cancer metastatic42 studii
- Insuficiență cardiacă42 studii
- Cancer de prostată36 studii
- Cancer colorectal33 studii
- Obezitate30 studii
- Cancer ovarian28 studii
- Cancer de vezică urinară27 studii
- Cancer pulmonar27 studii
- Cancer endometrial24 studii
- Boli cardiovasculare23 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.